Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias is a research paper published in RSC Medicinal Chemistry (2020). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01CA187678-01
National Science Foundation
Grant: DGE-1650504
NCI NIH HHS
Grant: T32 CA009120
NCI NIH HHS
Grant: R01 CA187678
NCI NIH HHS
Grant: P50 CA211015
National Institutes of Health
Grant: 5R01CA187678-02
PET Imaging-guided Personalized Therapy in Pancreatic Cancer
FWCI
0.46
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals